Rc. Albright et al., Patient survival and renal recovery in acute renal failure: Randomized comparison of cellulose acetate and polysulfone membrane dialyzers, MAYO CLIN P, 75(11), 2000, pp. 1141-1147
Citations number
27
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objective: To investigate survival and renal recovery after dialysis in pat
ients with acute renal failure with use of synthetic membranes compared wit
h substituted cellulose membranes.
Patients and Methods: We prospectively studied survival and recovery of ren
al function of 66 patients with acute renal failure who required intermitte
nt hemodialysis, Patients were randomized to exclusive treatment with eithe
r cellulose acetate (CA) or polysulfone (PS) hemodialysis membranes. Additi
onally, markers of biocompatibility (complement, leukocyte counts, cytokine
concentration) were measured at initiation and 1 hour after initiation of
dialysis among 10 patients equally distributed between the CA and PS groups
.
Results: The cohorts were indistinguishable with respect to age, sex, prese
nce of diabetes mellitus, Acute Physiology and Chronic Health Evaluation II
scores, percentage in the intensive care unit (ICU), and adequacy of dialy
sis, Survival (76% CA, 73% PS; P=.78) and recovery of renal function at 30
days (58% CA, 39% PS; P=.14) were not statistically different in the 2 grou
ps. Among 26 CA patients and 27 PS patients treated in the ICU, survival wa
s not statistically different (73% CA, 67% PS; P=.61); however, the proport
ion of patients recovering renal function suggested a benefit favoring CA m
embranes (65% CA, 37% PS; P=.04), Additionally, markers of biocompatibility
were not significantly different between groups among the 10 patients equa
lly distributed between the CA and PS groups.
Conclusions: Overall clinical outcomes among patients with acute renal fail
ure treated with CA hemodialysis membranes and those treated with PS membra
nes were not significantly different. The observed advantage favoring renal
recovery among this ICU population treated with CA hemodialysis membranes
warrants further investigation.